Cuidados
Continuos
93
BIBLIOGRAFIA
Peterson DE, Lalla RV. Oral mucositis: the new paradigms. Curr Opin Oncol. 2010 Jul;22(4):318-22
Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0, June 2010, National
Institutes of Health, National Cancer Institute.
Lima AG, Antequera R, Peres MP, Snitcosky IM, Federico MH, Villar RC. Efficacy of low-level laser
therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral
mucositis. Braz Dent J. 2010;21(3):186-92.
McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards
LK, Bowen J, Lalla RV; On behalf of the Mucositis Study Group of the Multinational Association
of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic
review of basic oral care for the management of oral mucositis in cancer patients. Support Care
Cancer. 2013 Nov;21(11):3165-77.
Wardill HR, Bowen JM. Chemotherapy-induced mucosal barrier dysfunction: an updated review on
the role of intestinal tight junctions. Curr Opin Support Palliat Care. 2013 Jun;7(2):155-61.
Mancini I, Bruera E. Constipation in advanced cancer patients. Support Care Cancer. 1998
Jul;6(4):356-64.
Rodriguez-Frias EA1, Lee WM Cancer chemotherapy II: atypical hepatic injuries. Clin Liver Dis.
2007 Aug;11(3):663-76.
King PD, Perry MC. Hepatotoxicity of chemotherapy. Oncologist. 2001;6(2):162-76.
Thatishetty AV1, Agresti N, O’Brien CB. Chemotherapy-induced hepatotoxicity. Clin Liver Dis. 2013
Nov;17(4):671-86
1.
2.
3.
4.
5.
6.
7.
8.
9.